SCHEMBL5590248

SCHEMBL5590248

CCCCc1cc(O)c(O)c(C(=O)O)c1CCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.47
PTPN11 Q06124 1/20 0.47
BID P55957 6/20 0.47
MCL1 Q07820 6/20 0.47
BCL2L1 Q07817 5/20 0.47
BAK1 Q16611 5/20 0.47
KAT8 Q9H7Z6 2/20 0.47
LDHA P00338 2/20 0.47
LDHB P07195 2/20 0.47
PPARG P37231 2/20 0.47
PPARA Q07869 2/20 0.47
SAE1 Q9UBE0 2/20 0.47
EP300 Q09472 1/20 0.47
KAT2A Q92830 1/20 0.47
KAT2B Q92831 1/20 0.47
KAT5 Q92993 1/20 0.47
SLC6A3 Q01959 1/20 0.44
TRPM7 Q96QT4 1/20 0.44
DAGLA Q9Y4D2 1/20 0.44
PTGES O14684 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5680885 0.95 BID (0.52) PTPN1PTPN11BIDMCL1BCL2L1
SCHEMBL5586645 0.95 BID (0.48) PTPN1PTPN11BIDMCL1BCL2L1
SCHEMBL5676358 0.94 PTPN1 (0.51) PTPN1PTPN11BIDMCL1BCL2L1
SCHEMBL5680898 0.92 BID (0.52) PTPN1BIDMCL1BCL2L1BAK1
SCHEMBL5676325 0.92 BID (0.52) PTPN1BIDMCL1BCL2L1BAK1
SCHEMBL5588619 0.92 PTPN1 (0.56) PTPN1PTPN11BIDMCL1BCL2L1
SCHEMBL5588174 0.91 BID (0.54) PTPN1BIDMCL1BCL2L1BAK1
SCHEMBL5193688 0.91 BID (0.47) PTPN1PTPN11BIDMCL1BCL2L1
SCHEMBL5589527 0.89 BID (0.56) PTPN1BIDMCL1BCL2L1BAK1
SCHEMBL5588741 0.89 BID (0.56) PTPN1BIDMCL1BCL2L1BAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 PTPN1 4679/4885PTPN11 4354/4885BID 1517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.